Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice2020 · 61 citations
2. 2The role of MET in chemotherapy resistance2021 · 113 citations
3. 3Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer2021 · 295 citations
4. 4Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring <scp><i>MET</i></scp> exon 14 skipping mutation2021 · 18 citations
5. 5The Many Faces of MDM2 Binding Partners2012 · 63 citations